Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
NAP1L5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
NAP1L5 - Schizophrenia: postmortem anterior prefrontal cortex
NAP1L5 - Primary and secondary brain tumors: glioblastomas, astrocytomas and oligodendrogliomas
NAP1L5 - Schizophrenia: endothelial and neuronal cells from postmortem dorsolateral prefrontal cortex tissue
NAP1L5 - Various stages of Alzheimer's disease: laser-captured hippocampal CA1 gray matter
NAP1L5 - Postmortem temporal cortex from Medical Research Council Cognitive Function and Ageing Study (MRC-CFAS) cohort: astrocytes
NAP1L5 - Parkinson's disease: substantia nigra (HG-U133B)
NAP1L5 - Parkinson's disease: substantia nigra
NAP1L5 - Colorectal tumor cell response to X radiation (19K 3 Part A)
NAP1L5 - Schizophrenia: postmortem superior temporal cortex
NAP1L5 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
NAP1L5 - Multiple sclerosis: brain lesions
NAP1L5 - Two types of HIV-associated neurocognitive impairment: brain regions
NAP1L5 - Alzheimer's disease: neurofibrillary tangles
NAP1L5 - Gliomas of grades III and IV (HG-U133B)
NAP1L5 - Glioma-derived stem cell factor effect on angiogenesis in the brain
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on